4//SEC Filing
BUCHEN DAVID A 4
Accession 0001723128-19-000009
CIK 0001723128other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:56 PM ET
Size
7.4 KB
Accession
0001723128-19-000009
Insider Transaction Report
Form 4
BUCHEN DAVID A
SVP, Chief Legal Officer
Transactions
- Award
Stock Option
2019-01-03+227,273→ 227,273 totalExercise: $13.58Exp: 2029-01-03→ Class A Common Stock (227,273 underlying) - Award
Restricted Stock Units
2019-01-03+110,457→ 110,457 total→ Class A Common Stock (110,457 underlying)
Footnotes (3)
- [F1]The option vests in four equal annual installments beginning on January 3, 2020.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]The restricted stock units vest in four equal annual installments beginning on January 3, 2020 and have no expiration date.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001241751
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:56 PM ET
- Size
- 7.4 KB